Atea Pharmaceuticals (AVIR) Receivables - Other (2020)
Atea Pharmaceuticals (AVIR) has 1 years of Receivables - Other data on record, last reported at $5.8 million in Q4 2020.
- For Q4 2020, Receivables - Other changed N/A year-over-year to $5.8 million; the TTM value through Dec 2020 reached $5.8 million, changed N/A, while the annual FY2020 figure was $5.8 million, N/A changed from the prior year.
- Receivables - Other reached $5.8 million in Q4 2020 per AVIR's latest filing.
- Across five years, Receivables - Other topped out at $5.8 million in Q4 2020 and bottomed at $5.8 million in Q4 2020.